Cargando…

Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial-mesenchymal transition

Metastasis is the most common cause of death in ovarian cancer patients but remains largely untreated. Epithelial-mesenchymal transition (EMT) is critical for the conversion of early-stage ovarian tumors into metastatic malignancies. Thus, investigating the signaling pathways promoting EMT may ident...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Dan-Hua, Yang, Jiang, Gao, Li-Kun, Min, Jie, Tang, Jian-Ming, Hu, Ming, Li, Yang, Li, Su-Ting, Chen, Jing, Hong, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313075/ https://www.ncbi.nlm.nih.gov/pubmed/30483796 http://dx.doi.org/10.3892/or.2018.6888

Ejemplares similares

Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer
por: Chen, Cong, et al.
Publicado: (2015)

Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis
por: Shao, Peng, et al.
Publicado: (2017)

Epigenetic Role of Histone Lysine Methyltransferase and Demethylase on the Expression of Transcription Factors Associated with the Epithelial-to-Mesenchymal Transition of Lung Adenocarcinoma Metastasis to the Brain
por: Lee, Young Min, et al.
Publicado: (2020)

lncRNA H19 is involved in TGF-β1-induced epithelial to mesenchymal transition in bovine epithelial cells through PI3K/AKT Signaling Pathway
por: Yang, Wei, et al.
Publicado: (2017)

Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A
por: Yang, Chao, et al.
Publicado: (2022)

Histone lysine demethylases in Drosophila melanogaster
por: Holowatyj, Andreana, et al.
Publicado: (2015)

Regulation of epithelial-mesenchymal transition by protein lysine acetylation
por: Kong, Fanyun, et al.
Publicado: (2022)

Chemical Biology of Lysine Demethylases
por: Heightman, Tom D
Publicado: (2011)

Histone demethylase lysine demethylase 5B in development and cancer
por: Han, Mengjiao, et al.
Publicado: (2016)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

Functional Characterization of the Lysine-Specific Histone Demethylases Family in Soybean
por: Liu, Mengshi, et al.
Publicado: (2022)

Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors
por: Shi, Ying, et al.
Publicado: (2018)

Targeting histone lysine demethylases — Progress, challenges, and the future()
por: Thinnes, Cyrille C., et al.
Publicado: (2014)

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
por: Deng, Junli, et al.
Publicado: (2019)

Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition
por: Zhong, Yi-Cun, et al.
Publicado: (2013)

UBE2T regulates epithelial–mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer
por: Cui, Ping, et al.
Publicado: (2022)

The emerging role of histone lysine demethylases in prostate cancer
por: Crea, Francesco, et al.
Publicado: (2012)

Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells
por: Zi, Dan, et al.
Publicado: (2015)

Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
por: Ramadoss, S, et al.
Publicado: (2017)

Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
por: Yang, Hui-Wen, et al.
Publicado: (2023)

Discovery of orally active chalcones as histone lysine specific demethylase 1 inhibitors for the treatment of leukaemia
por: Li, Yang, et al.
Publicado: (2020)

Histone lysine demethylases in mammalian embryonic development
por: Shen, Hongjie, et al.
Publicado: (2017)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via the PI3K/Akt pathway
por: Li, Jiang, et al.
Publicado: (2023)

JMJD8 Functions as a Novel AKT1 Lysine Demethylase
por: Wang, Yujuan, et al.
Publicado: (2022)

Lysine-specific demethylase 1 inhibitor rescues the osteogenic ability of mesenchymal stem cells under osteoporotic conditions by modulating H3K4 methylation
por: Lv, Longwei, et al.
Publicado: (2016)

Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway
por: Zang, Ming-de, et al.
Publicado: (2017)

Erratum: Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
por: Ramadoss, S, et al.
Publicado: (2017)

Prominent role of histone lysine demethylases in cancer epigenetics and therapy
por: Janardhan, Avilala, et al.
Publicado: (2018)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

TRPM7 promotes the epithelial–mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling
por: Liu, Lu, et al.
Publicado: (2019)

Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells
por: Qian, Xue-qian, et al.
Publicado: (2020)

Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies
por: Chao, Angel, et al.
Publicado: (2017)

Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway
por: Yeh, Yen-Hsiu, et al.
Publicado: (2018)

Androgen Receptor and Histone Lysine Demethylases in Ovine Placenta
por: Cleys, Ellane R., et al.
Publicado: (2015)

Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing α(Ⅴ)β(3) integrin/FAK/PI3K/Akt signaling activation
por: Chen, Yan, et al.
Publicado: (2019)

Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1
por: Chen, Jing-Yi, et al.
Publicado: (2016)

DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway
por: Li, Jian, et al.
Publicado: (2023)

Lysine-specific demethylase 1 mediates epidermal growth factor signaling to promote cell migration in ovarian cancer cells
por: Shao, Genbao, et al.
Publicado: (2015)

Inhibition of lysine-specific demethylase 1 prevents proliferation and mediates cisplatin sensitivity in ovarian cancer cells
por: Shao, Genbao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vhso8jpvbhi1k98cg3a374bfcu